by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis
Musculoskeletal research findings What was already known? Rheumatoid arthritis (RA) is a chronic disease that is associated with joint inflammation. Previous studies have shown that, by 20 years after diagnosis, patients reported severe levels of disability and pain,...
by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis
Musculoskeletal research findings What was already known? Patients with rheumatoid arthritis (RA) are at higher risk of heart attacks (myocardial infarction; MI) than the general population, which is partly explained by the effect of inflammation associated with RA on...
by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis
Musculoskeletal research findings What was already known? Biologic drugs that are used to treat rheumatoid arthritis (RA) act by targeting inflammatory molecules in the body. They are usually very effective but, in about one in five patients where biologics work...
by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis
Musculoskeletal research findings What was already known? Anti-TNF drugs (e.g. etanercept, certolizumab, adalimumab and golimumab) are biologic drugs that have radically improved treatment options for patients with Rheumatoid Arthritis (RA). Currently, there are 4...
by Web team (HR) | Feb 8, 2019 | Rheumatoid arthritis
Musculoskeletal research findings What we found? Arthritis Research UK-funded scientists have identified a new way in which genotyping can be used to predict disease outcomes among sufferers of rheumatoid arthritis. New cohort studies have shown that certain genetic...
Recent Comments